Citius Pharmaceuticals Inc —— 财务报表 (NASDAQ:CTXR) | MetaTrader

展开完整图表

新闻

Citius Oncology公布LYMPHIR 1期试验积极数据

Citius Oncology淋巴瘤研究显示86%的缓解率

Gold Edges Lower; Omeros Shares Jump - AMC Entertainment Hldgs (NYSE:AMC), Citius Pharmaceuticals (NASDAQ:CTXR)

Dow Gains Over 100 Points; US Jobless Claims Decline - Citius Pharmaceuticals (NASDAQ:CTXR), Multi Ways Holdings (AMEX:MWG)

Stock Market Today: Dow Jones, S&P 500 Futures Drop On Christmas Eve Despite Strong Q3 GDP Report—UiPath, AST SpaceMobile, Ramaco Resources In Focus - SPDR S&P 500 (ARCA:SPY)

Citius Pharmaceuticals (CTXR) Surges 22% After Hours — Here's Why

Citius Pharma launches cancer immunotherapy LYMPHIR in the U.S.

Citius Oncology完成1800万美元融资支持LYMPHIR商业化推广

Citius Oncology股价在1800万美元融资后暴跌

Citius Oncology stock tumbles after $18M capital raise

Citius Oncology融资1800万美元支持癌症疗法上市

Citius Oncology将Lymphir分销扩展至土耳其和中东地区